|1.||Liu, Ming-Yie: 10 articles (01/2013 - 03/2006)|
|2.||Hsu, Dur-Zong: 9 articles (01/2013 - 03/2006)|
|3.||Chopra, Kanwaljit: 5 articles (01/2015 - 03/2008)|
|4.||Chu, Pei-Yi: 5 articles (01/2013 - 03/2006)|
|5.||Periasamy, Srinivasan: 4 articles (01/2013 - 01/2010)|
|6.||Kuhad, Anurag: 4 articles (04/2011 - 03/2008)|
|7.||Sheu, Joen-Rong: 3 articles (02/2015 - 05/2011)|
|8.||Kaur, Indu Pal: 3 articles (02/2015 - 03/2006)|
|9.||Nayak, Pawan G: 3 articles (07/2013 - 01/2011)|
|10.||Li, Ya-Hui: 3 articles (10/2008 - 03/2006)|
|1.||Body Weight (Weight, Body)
01/01/2010 - "Administration of sesamol at different doses 50, 100 and 200 mg/kg body weight intraperitoneally for 7 days prevented the above changes and improved towards normality; the 50 mg dose was more effective than the other two doses."
08/01/2012 - "Administration of sesamol (50, 100 and 200 mg/kg of body weight) improved the above changes and brought towards normal level. "
09/01/2015 - "C57BL/6 mice were administered intraperitoneally with either sesamol or melatonin (10 and 20mg/kg body weight) 30 min prior to 2-Gy whole-body irradiation (WBI) and sacrificed after 24h. "
06/01/2013 - "Niacin (100 mg/kg) and sesamol (100 mg/kg) significantly (P < 0.05) reduced the elevated body weight compared with the high fat diet control group. "
10/01/2010 - "Diabetic rats developed neuropathy, which was evident from a marked hyperalgesia and allodynia associated with enhanced nitrosative stress, release of inflammatory mediators (TNF-α, IL-1β, TGF-1β), and caspase 3. Chronic treatment with sesamol (2, 4, and 8 mg/kg body weight; po) for 4 weeks starting from the 4th week of STZ injection significantly attenuated behavioral, biochemical, and molecular changes associated with diabetic neuropathy. "
03/28/2001 - "As part of our earlier search for new compounds with improved biological activities including antioxidant, anti-inflammatory, and tumor growth inhibition activities, we synthesized 2,4,5-trihydroxybenzaldehyde (2,4,5-THBA) from commercially available Sesamol. "
01/01/2014 - "The study clearly demonstrated the potentiality of sesamol against CPinduced organ toxicity and oxidative stress suggesting its applicability in treatment regime of cancer and other stress-associated disorders as a supportive/auxiliary therapy."
11/01/2013 - "Sesamol, a phenolic derivative present in sesame seeds is an exceptionally promising drug with lots of reports on its protective functions, including its inhibitory effects on platelet aggregation at concentrations below 100 μM, and its anti-cancer effect at 1 mM. However, the present study explored the toxic effects of sesamol on human platelets. "
11/01/2013 - "Sesamol, a nutritional antioxidant phenolic compound present in sesame seed, has a potential therapeutic molecule effect against cancers. "
09/28/2011 - "In conclusion, sesamol could concurrently induce apoptosis through the activation of the caspase pathway and steroidogenesis through the induction of StAR protein expression in MA-10 mouse Leydig tumor cells."
03/01/2011 - "In the present study, we synthesized a modified form of sesamol (INV-403) to enhance its properties and assessed its effects on atherosclerosis. "
02/27/2015 - "Our findings suggest that sesamol (1) protects against atherosclerosis by reducing L5-induced atherogenicity. "
03/01/2011 - "A modified sesamol derivative inhibits progression of atherosclerosis."
08/01/2015 - "Our study is novel in elucidating the molecular and cellular mechanisms underlying the protective effects of sesamol and sesame oil against atherosclerosis."
02/27/2015 - "We examined the effects of sesamol (1), a natural organic component of sesame oil, on plasma L5 levels and atherosclerosis development in a rodent model and on the L5-induced apoptosis of ECs. "
01/01/2011 - "We tested the hypothesis that sesamol's protection against myocardial infarction is associated with the inhibition of matrix metalloproteinase (MMP)-2 and MMP-9. "
01/01/2010 - "This study was designed to investigate the cardioprotective effect of sesamol on isoproterenol (ISO)-induced myocardial infarction in adult male albino Wistar rats. "
08/01/2012 - "The protective role of sesamol against isoproterenol-induced myocardial infarction was further confirmed by histopathological examination. "
01/01/2011 - "Sesamol effectively prevented myocardial infarction, at least in part, by controlling proteolytic activities and the expression of MMP-2 and -9 in isoproterenol-treated rats."
01/01/2011 - "Four groups of experimental rats were subcutaneously injected with sesamol (0, 1, 3, or 10 mg/kg) and then, 2 h later, intraperitoneally injected with isoproterenol (100 mg/kg 24 h apart on 2 consecutive days) to induce myocardial infarction. "
03/01/2006 - "The results from biochemical and histopathological investigations clearly confirm that the sesamol formulation is effective in preventing photodamage (lesions, ulcers and changes in skin integrity) due to chronic UV exposure."
04/01/1987 - "Histological examination of the forestomach showed that BHA induced hyperplasia mainly in the prefundic region near the esophageal orifice, caffeic acid induced pronounced hyperplasia throughout the forestomach epithelium, and sesamol induced large ulcers and hyperplasia in the central region. "
|1.||Sesame Oil (Oil, Sesame)
|3.||Glutathione (Reduced Glutathione)
|10.||Reactive Oxygen Species (Oxygen Radicals)
|4.||Drug Therapy (Chemotherapy)